⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Kotak Manufacture in India Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Kotak MF | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹22.49 (29 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | Nifty India Manufacturing - TRI | BSE Health Care - TRI |
| Fund Manager | Harsha Upadhyaya | Nikhil Mathur |
| Inception | 22 Feb 2022 | 04 Oct 2023 |
| Returns | ||
| 1Y | 7.53% | 22.64% |
| 3Y | 19.29% | 30.41% |
| 5Y | — | — |
| Since Inception | 18.88% | 29.15% |
| Risk | ||
| 15.21 | 14.07 | |
| 0.92 | 0.59 | |
| 0.90 | 1.59 | |
| 3.39 | 21.67 | |
| 1.69 | 3.48 | |
| -10.78% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.77% | 1.03% |
| Exit Load | 0.50% on or before 90D, Nil after 90D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Kotak MF89%
HDFC MF89%
10.6%Only 10.6% of holdings by weight are common between Kotak MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingKotak MFHDFC MF
Sun Pharmaceutical Industries Ltd.4.35%8.28%
Divi's Laboratories Ltd.3.71%9.39%
Rubicon Research Ltd.4.31%2.52%
Category context: Equity vs Equity. Open the full Screener →